Guest Editorial An opportunity for Trump: Position U.S. cancer science to lead the world May 16, 2025Vol.51 No.19By Wafik S. El-Deiry
Trump administration is removing the mainstays of NCI and the federal government’s cancer programPeer review, registries, and evidence-based patient information take a big hit May 09, 2025Vol.51 No.18By Paul Goldberg and Jacquelyn Cobb
Cancer Policy $180M in NCI grants have been terminated by Trump administration, systematic review finds May 09, 2025Vol.51 No.18By Jacquelyn Cobb
Clinical Roundup Incidence rates of some cancer types have risen in people under age 50, NCI study shows May 09, 2025Vol.51 No.18
News Analysis NIH eliminates the NCI Board of Scientific AdvisorsOver its 28 year history, BSA shaped NCI-funded extramural science May 02, 2025Vol.51 No.17By Paul Goldberg
Bertagnolli: NIH funding cuts are “unprecedented and harmful”AACR panel challenges scientists to find stability in a period of “ventricular tachycardia” May 02, 2025Vol.51 No.17By Claire Marie Porter
Cancer Policy HHS ordered to cut 35% of spending on contracts May 02, 2025Vol.51 No.17By Jacquelyn Cobb
In Brief David Ryan named president of Mass General Brigham Cancer Institute May 02, 2025Vol.51 No.17
Conversation with The Cancer Letter Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health April 25, 2025Vol.51 No.16By Paul Goldberg
Regulatory News Makary vows to speed up drug approvals and end FDA’s “cozy” relationship with industryCommissioner promises to protect scientific integrity while bringing in “fresh” MAHA ideas April 25, 2025Vol.51 No.16By Claire Marie Porter
